ElizabethMittendorfMD

PubMed

• Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow.
  Milos Spasic, Esther R Ogayo, Adrienne M Parsons, Peter van Galen, Sandra S McAllister, Elizabeth A Mittendorf> ;Cancer Research Communications. 2024 Mar 25
• Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer.
  Sreyashi Basu, Sonali Jindal, Zhong He, Khoi Chu, Akshara Singareeka Raghavendra, Haven R Garber, Clinton Yam, Lumarie Santiago, Beatriz E Adrada, Padmanee Sharma, Eli...> ;Oncotarget. 2024 Mar 19
• Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.
  Qiao, N., Guerriero, J., Gross, B., Meneksedag, Y., Lu, Y., Philips, A., Roszik, J., Chen, K., Peoples, G., Alatrash, G., Goldberg, J., Rahman, T., Meric-Bernstam, F.,...> ;Cancer Research Communications. 2024 Feb 22
• Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer.
  Ajari, O., Graham, N., Vincuilla, J., Parker, T., Hughes, M., Tayob, N., Morganti, S., Curigliano, G., Tarantino, P., Garrido-Castro, A., King, T., Mittendorf, E., Lin...> ;European Journal of Cancer. 2024 Apr 1
• Transforming the Future of Surgeon-Scientists.
  Ladner, D., Goldstein, A., Billiar, T., Cameron, A., Carpizo, D., Chu, D., Coopersmith, C., DeMatteo, R., Feng, S., Gallagher, K., Gillanders, W., Lal, B., Lipshutz, G...> ;Annals of Surgery. 2024 Feb 1
• ASO Visual Abstract: Defining the Biology of Estrogen Receptor-Low Positive Breast Cancer.
  Higgins, T., Harrison, B., Giordano, J., McGrath, M., Kantor, O., Burstein, H., Schnitt, S., Rahman, T., Vora, H., Garrido-Castro, A., Tolaney, S., Meric-Bernstam, F.,...> ;Annals of Surgical Oncology. 2024 Apr 1
• ASO Visual Abstract: Long-Term Patient-Reported Arm Symptoms in Breast Cancer Survivors.
  Lagendijk, M., Grossmith, S., Hughes, M., Eliassen, A., Laws, A., Lin, N., Mittendorf, E., King, T., Dominici, L.> ;Annals of Surgical Oncology. 2024 Apr 1
• Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer.
  Guerriero, J., Lin, J., Pastorello, R., Du, Z., Chen, Y., Townsend, M., Shimada, K., Hughes, M., Ren, S., Tayob, N., Zheng, K., Mei, S., Patterson, A., Taneja, K., Met...> ;NPJ Breast Cancer. 2024 Jan 2
• 1 citations
  Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
  Higgins, T., Harrison, B., Giordano, J., McGrath, M., Kantor, O., Burstein, H., Schnitt, S., Rahman, T., Vora, H., Garrido-Castro, A., Tolaney, S., Meric-Bernstam, F.,...> ;Annals of Surgical Oncology. 2024 Apr 1
• Long-Term Patient-Reported Arm Symptoms in Breast Cancer Survivors.
  Lagendijk, M., Grossmith, S., Hughes, M., Eliassen, A., Laws, A., Lin, N., Mittendorf, E., King, T., Dominici, L.> ;Annals of Surgical Oncology. 2024 Mar 1
• ASO Visual Abstract: Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy.
  Christina A Minami, Ginger Jin, Rachel A Freedman, Mara A Schonberg, Tari A King, Elizabeth A Mittendorf> ;Annals of Surgical Oncology. 2024 Feb 1
• ASO Visual Abstract: Racial and Ethnic Disparities in Outcomes after Breast-Conserving Therapy and Endocrine Therapy for DCIS-A Post Hoc Analysis of the NSABP B-35 Ran...
  Olga Kantor, Tari A King, Alyssa Jones, Charity Glass, Saskia J Leonard, Esther R Ogayo, Erica L Mayer, Mariana Chavez-MacGregor, Lisa A Newman, Rachel A Freedman, Eli...> ;Annals of Surgical Oncology. 2024 Feb 1
• Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy.
  Christina A Minami, Ginger Jin, Rachel A Freedman, Mara A Schonberg, Tari A King, Elizabeth A Mittendorf> ;Annals of Surgical Oncology. 2024 Feb 1
• Selecting Triple Negative Breast Cancer Patients for Immunotherapy.
  Stephanie Downs-Canner, Elizabeth A Mittendorf> ;Surgical Oncology Clinics of North America. 2023 Oct 1
• Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial.
  Olga Kantor, Tari A King, Alyssa Jones, Charity Glass, Saskia J Leonard, Esther R Ogayo, Erica L Mayer, Mariana Chavez-MacGregor, Lisa A Newman, Rachel A Freedman, Eli...> ;Annals of Surgical Oncology. 2023 Dec 1
• ASO Visual Abstract: Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the...
  Charity C Glass, Robert M Pride, Rachel A Freedman, Erica L Mayer, Esther R Ogayo, Mariana Chavez-MacGregor, Tari A King, Elizabeth A Mittendorf, Olga Kantor> ;Annals of Surgical Oncology. 2024 Jan 1
• Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical ...
  Charity C Glass, Robert M Pride, Rachel A Freedman, Erica L Mayer, Esther R Ogayo, Mariana Chavez-MacGregor, Tari A King, Elizabeth A Mittendorf, Olga Kantor> ;Annals of Surgical Oncology. 2023 Dec 1
• ASO Visual Abstract: Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront ...
  Robert M Pride, Charity C Glass, Faina Nakhlis, Alison Laws, Anna C Weiss, Jennifer R Bellon, Elizabeth A Mittendorf, Tari A King, Olga Kantor> ;Annals of Surgical Oncology. 2023 Oct 1
• 3 citations
  Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.
  Robert M Pride, Charity C Glass, Faina Nakhlis, Alison Laws, Anna C Weiss, Jennifer R Bellon, Elizabeth A Mittendorf, Tari A King, Olga Kantor> ;Annals of Surgical Oncology. 2023 Oct 1
• 1 citations
  Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospecti...
  Nour Abuhadra, Ryan Sun, Clinton Yam, Gaiane M Rauch, Qingqing Ding, Bora Lim, Alastair M Thompson, Elizabeth A Mittendorf, Beatriz E Adrada, Senthil Damodaran, Kiran ...> ;Cancers. 2023 Jun 21
• 2 citations
  A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
  Clinton Yam, Elizabeth A Mittendorf, Haven R Garber, Ryan Sun, Senthil Damodaran, Rashmi K Murthy, David Ramirez, Meghan Karuturi, Rachel M Layman, Nuhad Ibrahim, Gaia...> ;Breast Cancer Research and Treatment. 2023 Jun 1
• 8 citations
  Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx...
  Olga Kantor, Tari A King, Rachel A Freedman, Erica L Mayer, Mariana Chavez-MacGregor, Larissa A Korde, Joseph A Sparano, Elizabeth A Mittendorf> ;JAMA Surgery. 2023 Jun 1
• 2 citations
  Peritumoral Lidocaine Injection: A Low-Cost, Easily Implemented Intervention to Improve Outcomes in Early-Stage Breast Cancer.
  Tessa Higgins, Elizabeth A Mittendorf> ;Journal of Clinical Oncology. 2023 Jun 20
• 1 citations
  Correction: Preoperative Immunotherapy Combined with Chemotherapy for Triple-Negative Breast Cancer: Perspective on the KEYNOTE-522 Study.
  Stephanie Downs-Canner, Elizabeth A Mittendorf> ;Annals of Surgical Oncology. 2023 Jun 1
• 4 citations
  Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two internationa...
  Anna Weiss, Olga Martínez-Sáez, Adrienne G Waks, Alison Laws, Monica McGrath, Leah Portnow, Eric Winer, María Rey, Marta Tapia, Aleix Prat, Ann H Partridge, Sara M Tol...> ;Cancer. 2023 Jun 15
• Join now to see all